Evidence map›Paper›PMID 33203436›Full record

ArticleClinical epigenetics2020

5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers.

Siyu Liu, Marcell Costa de Medeiros, Evan M Fernandez, Katie R Zarins, Raymond G Cavalcante, Tingting Qin, Gregory T Wolf, Maria E Figueroa, Nisha J D'Silva, Laura S Rozek and 1 more

Open access · goldAbstract read
In one paragraph

Article in Clinical epigenetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Siyu LiuDepartment of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Ave., Ann Arbor, MI, 48109-2218, USA.
Marcell Costa de MedeirosDepartment of Periodontics and Oral Medicine, University of Michigan, Ann Arbor, MI, 48104, USA.
Evan M FernandezDepartment of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Ave., Ann Arbor, MI, 48109-2218, USA.
Katie R ZarinsDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, 48109, USA.
Raymond G CavalcanteEpigenomics Core, University of Michigan, Ann Arbor, MI, 48109, USA.
Tingting QinDepartment of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Ave., Ann Arbor, MI, 48109-2218, USA.
Gregory T WolfDepartment of Otolaryngology-Head and Neck Surgery, Michigan Medicine, Ann Arbor, MI, 48109, USA.
Maria E FigueroaDepartment of Human Genetics and Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL, 33136, USA.
Nisha J D'SilvaDepartment of Periodontics and Oral Medicine, University of Michigan, Ann Arbor, MI, 48104, USA.
Laura S RozekDepartment of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, 48109, USA.
Maureen A SartorDepartment of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Ave., Ann Arbor, MI, 48109-2218, USA. sartorma@umich.edu.ORCID 0000-0001-6155-5702
University of Michigan · USWashtenaw Community College · USMichigan Medicine · USUniversity of Miami · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
Therapeutic Potential and Mechanism of Action of Potent Small Molecule InhibitorsP50CA097248 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WOLF, GREGORY T · 2002 to 2013
$25.3M
Improving Survival in Oral Cancer by Disruption of Tumor ProgressionR35DE027551 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI D'SILVA, NISHA J · 2017 to 2024
$8.1M
Downstream effects of HPV integration on survival/metastasis in oropharyngeal cancerR01CA250214 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI D'SILVA, NISHA J, ROZEK, LAURA · 2020 to 2024
$3.1M
Integrative epigenomic/genomic profiling and biomarker discovery in HPV+ and HPV-R01CA158286 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROZEK, LAURA, SARTOR, MAUREEN AGNES · 2011 to 2015
$2.6M
5-hydroxymethylcytosine in HPV(+) and HPV(-) oral and oropharyngeal cancersR21CA187537 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SARTOR, MAUREEN AGNES · 2015 to 2016
$370k
NCI NIH HHS P30 CA046592NCI NIH HHS P50 CA097248NCI NIH HHS R01 CA158286NCI NIH HHS R01 CA250214NCI NIH HHS R21 CA187537NIDCR NIH HHS R35 DE027551
6 · The paper itself

Abstract

backgroundHead and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide, with human papillomavirus (HPV)-related HNSCC rising to concerning levels. Extensive clinical, genetic and epigenetic differences exist between HPV-associated HNSCC and HPV-negative HNSCC, which is often linked to tobacco use. However, 5-hydroxymethylation (5hmC), an oxidative derivative of DNA methylation and its heterogeneity among HNSCC subtypes, has not been studied.

resultsWe characterized genome-wide 5hmC profiles in HNSCC by HPV status and subtype in 18 HPV(+) and 18 HPV(-) well-characterized tumors. Results showed significant genome-wide hyper-5hmC in HPV(-) tumors, with both promoter and enhancer 5hmC able to distinguish meaningful tumor subgroups. We identified specific genes whose differential expression by HPV status is driven by differential hydroxymethylation. CDKN2A (p16), used as a key biomarker for HPV status, exhibited the most extensive hyper-5hmC in HPV(+) tumors, while HPV(-) tumors showed hyper-5hmC in CDH13, TIMP2, MMP2 and other cancer-related genes. Among the previously reported two HPV(+) subtypes, IMU (stronger immune response) and KRT (more keratinization), the IMU subtype revealed hyper-5hmC and up-regulation of genes in cell migration, and hypo-5hmC with down-regulation in keratinization and cell junctions. We experimentally validated our key prediction of higher secreted and intracellular protein levels of the invasion gene MMP2 in HPV(-) oral cavity cell lines.

conclusionOur results implicate 5hmC in driving differences in keratinization, cell junctions and other cancer-related processes among tumor subtypes. We conclude that 5hmC levels are critical for defining tumor characteristics and potentially used to define clinically meaningful cancer patient subgroups.

Indexed as

5-MethylcytosineCell MovementDNA MethylationEpigenesis, GeneticFemaleGene Expression Regulation, NeoplasticGenome-Wide Association StudyHead and Neck NeoplasmsHumansIntercellular JunctionsKeratinocytesMaleMiddle AgedPapillomaviridaePapillomavirus InfectionsSkin Neoplasms5-hydroxymethylcytosine5-MethylcytosineHead and neck cancerHuman papillomavirusHydroxymethylation

Identifiers

PMID33203436
PMCPMC7672859
OpenAlexW3099099313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.